Call us toll-free at 1-855-420-7140


When Detecting Lung Cancer, You Can’t Afford to Be Late. EarlyCDT®-Lung Can Help


Innovative Diagnostic Laboratory has launched the Find10Early™ campaign. We’re encouraging healthcare professionals to identify at least 10 of your patients at high-risk for lung cancer, and to perform EarlyCDT-Lung blood tests to help stratify their risk for developing lung cancer. The key advantage of EarlyCDT-Lung is its ability to help detect lung cancer at its earliest possible stages, when treatment can be most successful. EarlyCDT-Lung can help detect risk of lung cancer up to 5 years earlier than low-dose CT scan.3,4,5,7  

What Identifies a Patient as High Risk for Development of Lung Cancer? 


Age 50-75 smoker/ex-smoker > 20 pack-year* history
Age 45-49 smoker/ex-smoker 25-45 pack-year history and 2 additional risk factors (see below)
Age 45-49 smoker/ex-smoker with > 45 pack-year history and one additional risk factor (see below)
Age 40-44 smoker/ex-smoker with > 45 pack-year history and two additional risk factors
Patients with indeterminate pulmonary nodules

Additional risk factors include:
Family history of lung disease
Emphysema or chronic obstructive pulmonary disease (COPD)
Environmental exposures (radon, asbestos, coal products, radioactive substances)

* A Pack-Year is the number of packs smoked per day multiplied by the number of years smoked.

Clinical Studies

EarlyCDT-Lung results have been published in several peer reviewed journals (cited at bottom of page) including the Journal of Lung Cancer.

Click here to read performance study by Dr. James R. Jett